Why has Intel's stock price risen sharply, yet the company should instead take advantage of this opportunity to issue new shares?
- Core Perspective: Intel's most urgent task right now is not to buy back its own stock, but to take advantage of its strong stock price to raise equity capital. It needs to raise approximately $25 billion to provide key funding for its advanced process foundry capacity buildout and its transformation narrative, preventing it from missing its strategic window due to a lack of funds.
- Key Elements:
- Intel has already raised about $20 billion through strategic investments from the U.S. government, SoftBank, NVIDIA, and others. The entry prices for these investors (around $20-$23) are all below the current stock price, so issuing new shares would allow them to gain paper profits, rather than being a form of "punishment."
- Intel's past "Smart Capital" strategy of selling assets and introducing joint venture partners (such as Apollo, Brookfield) has proven costly. The company's recent $14.2 billion buyback of a wafer fab stake from Apollo confirms the high cost of yielding asset returns.
- With debt pressure of about $45 billion, Intel has limited room for further debt or asset sales. At its current market cap of approximately $498 billion, raising about $25 billion would require only a 4%-5% equity dilution, making it the cheapest source of capital.
- Market demand is already in place: orders from NVIDIA, Google, and potential major customers like SpaceX and Tesla provide a better pricing logic for equity financing tied to signed demand.
- Intel's projects like Terafab could cost up to $119 billion, and even if some capital is provided by partners, the company still needs to contribute hundreds of billions of dollars, far exceeding what its current operating cash flow can support.
- The current window for equity issuance is the widest it has been in recent times. With recent successful fundraising cases like Cerebras indicating a hot market sentiment, Intel should seize the opportunity to execute a "reverse buyback."
Original Title: Intel Should Raise Capital
Original Author: Semianalysis
Original Translation: Peggy, BlockBeats
Editor’s Note: Since breaking out of its consolidation range in early April, Intel's stock price has continued to recover, experiencing two key catalysts in June. First, the market reported that Google had placed an AI chip order with Intel, driving its stock price up sharply in a single day. Second, Bank of America unexpectedly upgraded Intel's rating directly from "Underperform" to "Buy," raising the price target from $96 to $135. Behind this rebound, the market is repricing not just Intel's short-term performance, but its strategic position in AI CPUs, advanced process foundry services, and the US domestic chip supply chain.
INTC Stock Price Trend
Now, Intel's transformation narrative is shifting from a "rescue mission" to a "re-expansion" phase. With Lip-Bu Tan taking over as CEO, a new board, and strategic capital from the US government, SoftBank, Nvidia, and others entering the scene, market expectations for Intel have clearly improved. However, this article reminds us that what truly determines whether Intel can return to the core table of advanced manufacturing is not just customer commitments or a stock price rebound, but whether it has enough capital to actually build out its foundry capacity.
The author believes that Intel's problems over the past decade largely stem from financial engineering: selling assets, bringing in joint venture partners, and using "Smart Capital" (reducing capital expenditure pressure through joint ventures and asset disposals) to ease cash flow stress, while also ceding long-term earnings from core assets like wafer fabs.
Now, the most important thing Intel should do is not buy back shares, but to conduct an equity offering while its stock is strong. The reason is straightforward: on one hand, the current valuation is already at a high level. A dilution of just 4% to 5% could raise approximately $250 billion, significantly enhancing Intel's ability to build advanced process capacity. On the other hand, the entry prices for the US government, SoftBank, and Nvidia were all lower than the current stock price. A secondary offering at this point wouldn't necessarily "penalize" new shareholders; it could instead increase book value per share and provide these strategic investors with paper gains.
More importantly, the alternative financing methods Intel has tried in the past have proven to be costly. Whether it was selling its NAND business, reducing its stake in Mobileye, ceding control of Altera, or bringing in partners like Apollo and Brookfield through SCIP (Semiconductor Co-Investment Program, exchanging long-term rights to wafer fab earnings for external capital), these essentially boiled down to trading assets and future earnings for cash. Now, Intel is spending $14.2 billion to buy back Apollo's stake in Fab 34, which precisely demonstrates that ceding the economic benefits of a fab was not cheap. Adding more debt would strain the balance sheet, and there is limited room for further asset sales. Equity, therefore, has become the cheapest and cleanest source of capital available.
Thus, the core judgment of this article is: Intel is no longer short on a "comeback story"; what it truly lacks is the capital needed to execute that story. Demand for Agentic CPUs (a new type of CPU designed for the AI agent era), potential major clients like SpaceX and Tesla, and orders from Nvidia and Google have given Intel a demand base it can present to the capital markets. For Intel, issuing new shares is not simply a dilutive move. It's about taking advantage of an open market window to acquire cheap capital in exchange for the execution rights to advanced process capacity, its foundry business, and the narrative of silicon sovereignty. Missing this window could prove more expensive than the financing itself.
Below is the original text (edited for readability):
We've written a lot about Intel. This company holds a special meaning for us; it is practically the starting point of the semiconductor industry. Simply saying we love Intel and believe in its role in the world still feels inadequate. In the past, we were very direct in pointing out problems during Intel's early product missteps. We have also consistently supported and held hope for its turnaround. One of our firmest convictions was that the Intel board was a major contributor to its decline. Recently, we finally saw the changes we've been wanting to see.
Frank Yeary just stepped down after 17 years on the board. The new board is now composed of people who truly understand the industry, not just financial engineering. The new chairman previously served at Qualcomm. Lip-Bu Tan is the CEO. Steve Sanghi from Microchip, Stacey Smith, and Eric Meurice from ASML are also on the board. In other words, this board finally understands the technology.
However, although Intel's transformation has partially begun, there is still a long road ahead to fully revitalize the company. Today, we believe that under this new board, Intel should make another major strategic bet: not buying back stock, but issuing enough shares to completely fix Intel's financial situation once and for all.
Lip-Bu Tan has already pulled Intel back from the brink, raising approximately $20 billion through investments from the US government, SoftBank, Altera, and Nvidia. Intel shouldn't stop halfway. It should continue to capitalize on the current strength of its stock price. In past terrible years, the company was a large net buyer of its own stock. Now is the time to issue equity while the stock is strong. If done correctly, this will make Intel's transformation much easier to succeed.
Note: Lip-Bu Tan is the CEO of Intel, appointed in March 2025, and also sits on the Intel board.
Equity Dilution Now Rewards Investors Who Have Already Bet
Take a look at the prices at which this capital came in. The US government subscribed for up to 433 million shares at $20.47 per share, representing a 9.9% stake at signing; as of the end of Q1, 149 million shares were still held in escrow. SoftBank's entry price was $23.00, and Nvidia's was $23.28. Currently, all these holders are sitting on unrealized gains.
Therefore, the intuition that raising funds would punish new investors is actually misguided. Issuing shares at today's price, far above these entry prices, will increase book value per share and generate paper gains for the US government, SoftBank, and Nvidia. That nearly 10% sovereign capital anchor itself is a significant reason Intel can execute a large-scale issuance at a lower cost. Intel is one of the very few companies globally that can sell a large amount of stock in a hot market while having the US government as a backstop. As long as this leverage exists, it's worth using.
Intel Needs Capital to Execute Its Transformation
Based on trailing twelve-month performance, Intel is almost as expensive now as it has been since the 2000 dot-com bubble. We believe the company's prospects are bright, but to achieve them, one of the most critical elements is capital. The current stock price does not fully reflect the real execution risk.
More importantly, even under the most optimistic scenario with renewed demand for Agentic CPUs, Intel cannot solely finance all the investments needed for an upside scenario. We believe it's time for Intel to execute a "reverse buyback": take advantage of the current market demand for stock offerings and issue equity.
Equity Is Now the Cheapest Capital Intel Can Get
Detractors might argue that Intel has other ways to finance its fabs. But it has tried them all and has just signaled to the market that these methods aren't ideal.
Apollo invested $11.2 billion for a 49% stake in the Fab 34 joint venture. Brookfield structured financing for the Arizona fab project. Silver Lake acquired 51% of Altera at an $8.75 billion enterprise value, bringing Intel approximately $4.3 billion in net cash. Intel also phased out its NAND business by selling it to SK Hynix and continued selling Mobileye shares. "Smart Capital" (a capital strategy using joint ventures and asset sales to reduce capital expenditure pressure) was once Intel's core narrative.
Then, on March 31, 2026, Intel agreed to buy back Apollo's 49% stake in Fab 34, completing the transaction on April 8th for a total of $14.2 billion, consisting of approximately $7.7 billion in cash and $6.5 billion in bridge loans. Management stated this buyback would be accretive to earnings, and they were right, which is the key point. If buying back the fab's equity is accretive, then selling the economic interest of the fab to a partner was, in essence, an expensive form of financing all along. SCIP essentially involves ceding a portion of the long-term earnings stream of the company's best assets to an external capital provider in exchange for funds that appeared cheaper on the surface but were actually more costly. Intel has now proven with its own checkbook that it prefers to own its fabs and take on the corresponding debt rather than continue ceding their earnings.
So, let's cross off the other options. Doing more SCIP is exactly the kind of choice management just spent $14.2 billion to reverse. Adding more debt would be layered on top of the existing $45 billion on the balance sheet; factoring in the Apollo bridge loan, the debt load would reach approximately $51.5 billion. Major asset sales are largely done; Mobileye and Altera have been either sold or had majority control ceded. What remains is equity financing. And at current valuation levels, equity is the cheapest capital Intel has.
With the announcement of the massive Terafab project and overflow demand from the severe N3 shortage, Intel's foundry business is just getting started. To truly seize this unique window, Intel must become a crucial supplier during the industry-wide shortage of advanced process wafer capacity. The capital required for this massive bet far exceeds what Intel can currently afford from its operating cash flow.
Just a 4% to 5% equity dilution could raise approximately $25 billion, which would be enough to turn the most optimistic supply capacity narrative into reality at this critical juncture.
Agentic CPU Demand Won't Cover the Terafab Bill
Commitments from large clients like SpaceX, Tesla, and the Terafab partners are key to solving the 14A capacity problem. The initial goal is to reach 100,000 wafers per month (WSPM), with a further expansion to 1 million wafers—this will be very difficult and put immense pressure on capital. But this step must happen because Lip-Bu Tan has publicly told the market: if there are no customers, he will shut down the foundry business. Now that customers are here, it's time to build.
Beyond the Terafab partners, Intel's order book is also filling up. Nvidia's DGX Rubin NVL8 configuration lists dual Intel Xeon 6 host CPUs. Google has signed a multi-year agreement covering Xeon and custom IPUs. SambaNova is also joining for inference workloads. The wafer volumes behind these orders haven't all been disclosed, but the capital market will fund a visible order book at a much lower cost than funding a turnaround story. Intel finally has orders it can point to. The pricing logic for raising equity against signed customer demand is completely different from raising equity against a mere promise.
Due to lower-than-expected CPU demand, Intel has been doing everything possible to delay capital spending in the past. But now, it's time to go all-in again, as in the Gelsinger era. This is a critical moment for silicon sovereignty, and Intel must continue to increase its bets.
Intel's complete multi-phase project could cost up to $119 billion. While SpaceX will provide initial capital, Intel must also make a meaningful contribution. Even marginal capital matching implies tens of billions of dollars in new funding requirements that simply weren't in Intel's capital expenditure decision matrix a month ago.
Now is the time to end the financial engineering of the past decade and issue shares immediately. Because although the capacity ramp-up is exciting, it will be very expensive. The current window for equity issuance is the widest it has been in some time. If Cerebras could raise $5.55 billion, Intel can raise $25 billion. This view is only strengthened by the fact that Intel's market cap of around $498 billion can easily support much larger subsequent offerings. Based on our observations, this window seems to be fully open. Below is some data from recent comparable offerings.
Transaction Window is Open
In other words, Intel's real problem is no longer "does it have a story," but "does it have enough capital to turn the story into capacity." With strategic capital from the US government, SoftBank, and Nvidia already in place, and advanced process supply in a state of scarcity, equity financing is no longer just a defensive move that dilutes shareholders. It could become an offensive move to restart Intel's foundry ambitions and bet on silicon sovereignty. For Intel, missing this financing window could prove far more expensive than the offering itself.
